BiVACOR’s Post

Perioperative Spinal Cord Injury in high-risk adult deformity surgeries has relatively low incidence, but can have devastating consequences. Thus, appropriate postoperative care, follow up, and timely management are essential, and these procedures should only be performed by experienced spine surgeons with skills and expertise in deformity correction. The recently published article from the AO Spine Knowledge Forum Deformity Scoli-RISK-1 study subanalysis shows a case series of SCI in this patients population. The study also highlights the need for standardized clinical practice guidelines for the management of perioperative SCI following complex deformity procedures. Read open access in Nature Magazine spinal cord series and cases 🔗 https://brnw.ch/21wM099 #KFDeformity #spine #aospine #deformity #spinalcordinjury

It's another FIRST for Joseph J. Ricotta MD, MS, DFSVS, FACS, National Medical Director, Vascular Surgery and Endovascular Therapy, Tenet Healthcare and the vascular team at Delray! Dr. Ricotta and his team are the first in Palm Beach County to place Abbott's Esprit™ BTK Everolimus Eluting Resorbable Scaffold! This is a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving. Previously, the standard of care has been balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow. However, blockages treated only with balloon angioplasty have poor short- and long-term results, and in many instances the vessels become blocked again, requiring additional treatment. The Esprit BTK System is a dissolvable stent and is comprised of material similar to dissolving sutures. The device is implanted during a catheter-based minimally invasive procedure via a small incision in the leg. Once the blockage is open, the Esprit BTK scaffold helps heal the vessel and provides support for approximately three years until the vessel is strong enough to remain open on its own. For more information on Dr. Ricotta and Prime Vascular Institute visit https://lnkd.in/e5bt7Y5E... We are #PBHNProud #strongertogetherforyou #palmbeachhealthnetwork #palmbeachhealthnetworkphysiciangroup #primevascularinstitute

NICHD established the Pelvic Floor Disorders Network (PFDN) in 2001 to encourage collaborative research and improve patient care on a common women’s health condition. Today, PFDN researchers published a new study in JAMA Surgery, where they directly compared three procedures that are performed to repair pelvic organ prolapse. From this randomized clinical trial, the study team found that all three surgeries are generally comparable and safe after three years. These findings provide healthcare providers and patients with clinical evidence to discuss the pros and cons of available surgeries and decide upon the most appropriate treatment. Learn more: https://go.nih.gov/tKVr2uU.

It's another FIRST for Joseph J. Ricotta MD, MS, DFSVS, FACS, National Medical Director, Vascular Surgery and Endovascular Therapy, Tenet Healthcare and the vascular team at Delray! Dr. Ricotta and his team are the first in Palm Beach County to place Abbott's Esprit™ BTK Everolimus Eluting Resorbable Scaffold! This is a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving. Previously, the standard of care has been balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow. However, blockages treated only with balloon angioplasty have poor short- and long-term results, and in many instances the vessels become blocked again, requiring additional treatment. The Esprit BTK System is a dissolvable stent and is comprised of material similar to dissolving sutures. The device is implanted during a catheter-based minimally invasive procedure via a small incision in the leg. Once the blockage is open, the Esprit BTK scaffold helps heal the vessel and provides support for approximately three years until the vessel is strong enough to remain open on its own. For more information on Dr. Ricotta and Prime Vascular Institute visit https://lnkd.in/e5bt7Y5E... We are #PBHNProud #strongertogetherforyou #palmbeachhealthnetwork #palmbeachhealthnetworkphysiciangroup #primevascularinstitute

A total of nine studies were included, and the results showed that both surgical modalities had good safety profiles in the early and long-term stages. For early endpoint events, the risk of all-cause mortality and major bleeding within 30 years was similar in the staged TAVR + PCI and the contemporaneous TAVR + PCI (P > 0.05). Additionally, the risk of myocardial infarction, stroke, acute kidney injury and pacemaker implantation within 30 days or perioperatively is similar (P > 0.05). For long-term endpoint events, the risk of all-cause mortality, myocardial infarction and stroke was similar in the two groups at ≥2 years (P > 0.05). In patients undergoing TAVR who required coronary revascularization, no significant differences were observed in the early and long-term outcomes between those receiving concurrent TAVR and PCI versus staged surgery.

A study aimed to see how often patients on blood thinners get immediate or delayed brain bleeding after a mild head injury and whether they need short-term hospital stays based on initial scans and symptoms. This study's review of 696 patients found that immediate brain bleeding occurred in 5.1% of cases, with no link to the type of blood thinner used and delayed bleeding was very rare. Symptoms like loss of consciousness and headache were indicators of higher risk, suggesting that initial scans alone should not determine the need for hospital observation. Source: Sakkas, A., Weiß, C., Wilde, F., Ebeling, M., Thiele, O.C., Mischkowski, R.A. and Pietzka, S., 2024. Impact of antithrombotic therapy on acute and delayed intracranial haemorrhage and evaluation of the need of short-term hospitalisation based on CT findings after mild traumatic brain injury: Experience from an oral and maxillofacial surgery unit. European Journal of Trauma and Emergency Surgery, 50(1), pp.157-172.

It's another FIRST for Joseph J. Ricotta MD, MS, DFSVS, FACS, National Medical Director, Vascular Surgery and Endovascular Therapy, Tenet Healthcare and the vascular team at Delray! Dr. Ricotta and his team are the first in Palm Beach County to place @Abbott's Esprit BTK Everolimus Eluting Resorbable Scaffold! This is a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving. Previously, the standard of care has been balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow. However, blockages treated only with balloon angioplasty have poor short- and long-term results, and in many instances the vessels become blocked again, requiring additional treatment. The Esprit BTK System is a dissolvable stent and is comprised of material similar to dissolving sutures. The device is implanted during a catheter-based minimally invasive procedure via a small incision in the leg. Once the blockage is open, the Esprit BTK scaffold helps heal the vessel and provides support for approximately three years until the vessel is strong enough to remain open on its own. For more information on Dr. Ricotta and @Prime Vascular Institute visit https://lnkd.in/ernivBk9 We are #DelrayMedicalCenter. #strongertogetherforyou #PBHNProud #palmbeachhealthnetwork #palmbeachhealthnetworkphysiciangroup

Here is a quick update on Regions Open Heart Surgery week! Two patients have undergone surgery and they are both doing great. 👏🏾👏🏾👏🏾👏🏾 The first case is a 64-year-old female. Diagnosed with Type A Aortic Dissection and Right Atrial hematoma. She had Repair of Type A aortic dissection with total arch replacement and excision of right atrial hematoma. The second case is a 58-year-old female, diagnosed with Coronary Artery Disease (3 vessels) and underwent a Coronary artery bypass graft x3. At Regions, we deal with complex cardiac surgeries. Cases that ordinarily can’t be done around and patients have to travel abroad! We have a comprehensive cardiac program that includes cardiologists, vascular cardiologists and cardiac surgeons. Book appointment to see our specialists today! For more information, please call 07047000010. …exceptional people providing exceptional healthcare. #Regionshealthcare #cardiacsurgery #openheart #cardiaccare #linkedin #hospitals #specialist #clinicaloperations

If you have patients battling chronic back pain that are not candidates for spine surgery, we've got some great news to share. According to NOVA randomized controlled trial (RCT)†, Medtronic DTM™ spinal cord stimulation (SCS) showed 93.5% of subjects had ≥50% back pain relief at 3-months and 76.0% subjects had ≥80% back pain relief at 12-months. (1) Medtronic has your patients' back with pain relief. See risk information: https://bit.ly/4aEH4OA See the data for yourself! Go to Medtronic.com/NOVA to see the results from the RCT. #MDTPainInterventions #SCS #SCSNOVA † The NOVA RCT examined SCS in patients with degenerative disc disease, herniated disc, or radicular pain syndrome. 1. White T, Justiz R, Almonte W, et al. DTM™ SCS for Indicated Chronic Back Pain Patients Non-Eligible for Spine Surgery: US RCT outcomes. Presented at: North American Neuromodulation Society (NANS) Annual Meeting. Jan. 18-21, 2024. Las Vegas, NV, USA.

A teenager with chest pain on exertion 16 y/o girl presented with chest pain during sport and decreased exercise tolerance. Cardiological work-up revealed myocardial bridging of the LAD over a length of 7 cm, with reversible ischemia on SPECT myocardial perfusion imaging. Given the morphology of intramyocardial course and severity of symptoms, surgical unroofing of the LAD was scheduled. Surgery was uneventful, with quick postoperative recovery. ·        Myocardial bridging is a common coronary anomaly, in which a coronary artery runs through heart muscle, needing multimodal imaging to find those needing treatment. ·        Beta-blockers and calcium-channel blockers are first treatments, with revascularization for those not responding to medication. ·        Revascularization options include PCI or surgical myotomy, chosen based on lesion specifics, atherosclerosis, expertise, and patient preference. https://lnkd.in/extx2xup